Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Press Statements

      Sandoz receives eighth European Commission approval for a biosimilar with Ziextenzo

      FDA Approvals
      Sandoz, a Novartis division and the pioneer and global leader in biosimilars, announced that the European Commission (EC) granted marketing authorization for biosimilar Ziextenzo®...

      AMAL Therapeutics raises CHF 33.2 Million Series B Round

      Clinical Trials
      AMAL Therapeutics SA , a Swiss biotech developing peptide-based therapeutic cancer vaccines, announces that it has completed the second closing of its Series B...

      Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure

      Clinical Trials
      Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, announced that it has initiated enrollment of patients into a first-in-human clinical...

      SIRIO Pharma opens multimillion gummy production plant at new high-tech nutraceutical facility in Ma’anshan, China

      Press Statements
      Sirio Pharma Co. Ltd – the global nutraceutical contract development and manufacturing organization (CDMO) announces the opening of a gummy production workshop plant at...

      European Commission has granted Marketing Authorization for Vertex’s SYMKEVI

      FDA Approvals
      Vertex Pharmaceuticals Limited, announced that the European Commission has granted Marketing Authorization for SYMKEVI in a combination regimen with ivacaftor for the treatment of...

      Roche announces FDA approval of Xofluza (baloxavir marboxil) for influenza

      FDA Approvals
      Roche announced that the US FDA has approved Xofluza™ (baloxavir marboxil) for the treatment of acute, uncomplicated influenza, or flu, in people 12 years...

      CRISPR Therapeutics and Vertex Announce FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for CTX001 for the Treatment of Sickle...

      Drug Development
      CRISPR Therapeutics , a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Vertex Pharmaceuticals Incorporated announced that the U.S. FDA...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.